---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-003048"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:23:07.548403+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Entero Therapeutics receives Nasdaq notice for missing 2024 annual meeting

## Summary
- Notice received Jan 7, 2025 for non-compliance with Nasdaq Listing Rule 5620(a) due to no 2024 annual meeting.
- Company has until Feb 21, 2025 to submit a compliance plan; extension possible to June 30, 2025.
- Intends to hold annual meeting as soon as practicable and will file a proxy statement.
- Notice has no immediate effect on listing or trading of common stock (ENTO).
- Failure to regain compliance may lead to delisting; company can appeal to Nasdaq hearings panel.

## SEC filing metadata
- accession: 0001104659-25-003048
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000110465925003048/0001104659-25-003048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000110465925003048/tm252903d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-003048
- JSON: https://secwatch.observer/filing/0001104659-25-003048.json
- Plain text: https://secwatch.observer/filing/0001104659-25-003048.txt

## Source-grounded claims
- claim_id: ce52b6076e297d0bf0cd6913ff58a92e6defa8d2
  claim: GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a)).
  evidence_excerpt: Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5620(a), due to the Company not holding an annual meeting of stockholders in 2024 within one year of the Compa
  evidence_url: https://www.sec.gov/Archives/edgar/data/1604191/000110465925003048/0001104659-25-003048-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
